| | 834153-87-6 Basic information More.. |
| Product Name: | elagolix | | Synonyms: | elagolix;4-[[(1R)-2-[5-(2-Fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]amino]butanoic acid;Butanoic acid, 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]amino]-;4-({(1R)-2-[5-(2-Fluoro-3-methoxyphenyl)-3-[2-fluoro-6-(trifluoromethyl)benzyl]-4-methyl-2,6-dioxo-3,6-dihydro-1(2H)-pyrimidinyl]-1-phenylethyl}amino)butanoic acid;4-[[(1R)-2-[5-(2-FLUORO-3-METHOXYPHENYL)-3-[[2-FLUORO-6-(TRIFLUOROMETHYL)PHENYL]METHYL]-4-METHYL-2,6-DIOXOPYRIMIDIN-1-YL]-1-PHENYLETHYL]AMINO]BUTANOIC ACID;elagolix USP/EP/BP;Seviram hydrochloride;Elagolix (NBI-56418) | | CAS: | 834153-87-6 | | MF: | C32H30F5N3O5 | | MW: | 631.59 | | EINECS: | | | Mol File: | 834153-87-6.mol |  |
Use
Elagolix is a gonadotropin-releasing hormone(GnRH) receptor antagonist indicated for the management of moderate to severe pain associated with endometriosis. Elagolix is an orally administered,nonpeptide small molecule gonadotropin-releasing hormone(GnRH) receptor antagonist that inhibits endogenousGnRH signaling by binding competitively to GnRH receptors in the pituitary gland.
- elagolix
-
- US $0.00-0.00 / KG
- 2024-04-23
- CAS:834153-87-6
- Min. Order: 1KG
- Purity: 0.99
- Supply Ability: 50MT/month
- Elagolix
-
- US $0.00 / kg
- 2024-04-12
- CAS:834153-87-6
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 2000ton
- elagolix
-
- US $300.00 / kg
- 2023-06-26
- CAS:834153-87-6
- Min. Order: 10kg
- Purity: 99%
- Supply Ability: 500kg/month
|
|
834153-87-6
Recommend Suppliers |
|